▁Introduction 7.8203125
: 1.9072265625
<0x0A> 6.52734375
Ind 6.5546875
ian 2.099609375
apolis 4.96484375
- 3.8984375
based 0.3642578125
▁ph 7.80078125
arma 0.228271484375
ce 0.045806884765625
ut 8.952617645263672e-05
ical 0.0009698867797851562
▁giant 1.892578125
, 5.5390625
▁Eli 0.027862548828125
▁L 0.002780914306640625
illy 0.00905609130859375
▁& 2.435546875
▁Co 0.69189453125
, 2.935546875
▁is 1.5361328125
▁set 4.30078125
▁to 0.02734375
▁announ 3.751953125
ce 4.982948303222656e-05
▁its 1.5546875
▁third 2.158203125
- 0.478759765625
qu 0.0027980804443359375
arter 2.5391578674316406e-05
▁ear 0.64404296875
nings 0.00782012939453125
, 4.33984375
▁and 2.3125
▁industry 6.16796875
▁exper 1.681640625
ts 0.00011551380157470703
▁anticip 3.61328125
ate 0.005706787109375
▁a 1.443359375
▁positive 3.478515625
▁traject 7.3671875
ory 0.0001609325408935547
▁for 0.95849609375
▁the 0.168701171875
▁company 0.533203125
. 0.66845703125
▁Ex 6.859375
pect 0.70703125
ations 0.053192138671875
▁are 0.50634765625
▁high 0.430908203125
▁for 1.3017578125
▁increased 6.25
▁prof 2.431640625
its 0.0007295608520507812
, 1.3583984375
▁driven 2.341796875
▁by 0.15283203125
▁robust 4.55859375
▁sales 0.69482421875
▁of 0.358154296875
▁key 2.28125
▁dru 0.95849609375
gs 1.5497207641601562e-05
▁amid 8.703125
▁the 2.142578125
▁on 1.8955078125
going 0.0103607177734375
▁COVID 1.314453125
- 0.0204620361328125
1 0.0019741058349609375
9 0.0001888275146484375
▁pan 0.09796142578125
demic 0.00012111663818359375
. 0.1580810546875
▁However 4.43359375
, 0.0006318092346191406
▁anal 2.869140625
yst 0.00042128562927246094
s 0.0162811279296875
▁are 1.3857421875
▁vo 6.94921875
icing 0.00015151500701904297
▁concerns 0.5556640625
▁over 0.8779296875
▁potential 3.0625
▁profit 6.31640625
▁margin 1.6533203125
▁challeng 4.42578125
es 0.00011360645294189453
▁faced 6.04296875
▁by 0.06524658203125
▁the 0.50439453125
▁company 0.345947265625
. 1.072265625
▁This 3.482421875
▁article 0.453857421875
▁del 2.46484375
ves 0.005191802978515625
▁into 0.1590576171875
▁the 0.509765625
▁factors 2.8359375
▁contrib 2.79296875
uting 2.6106834411621094e-05
▁to 0.0028667449951171875
▁elev 8.6171875
ated 0.0023040771484375
▁prof 3.208984375
its 0.0009264945983886719
, 1.4462890625
▁while 3.087890625
▁expl 2.6640625
oring 0.00010311603546142578
▁the 0.69189453125
▁underlying 3.421875
▁concerns 2.470703125
▁surrounding 2.17578125
▁Eli 1.4052734375
▁L 0.0022640228271484375
illy 0.0015048980712890625
▁& 2.076171875
▁Co 0.0106353759765625
' 1.6474609375
s 0.0006656646728515625
▁profit 1.6142578125
▁marg 1.3720703125
ins 0.00012159347534179688
. 0.1036376953125
<0x0A> 0.09515380859375
R 4.53125
ising 0.42041015625
▁Prof 2.291015625
its 0.1751708984375
▁Am 3.04296875
id 0.00020825862884521484
▁Pan 2.4140625
demic 0.0006656646728515625
: 0.6015625
<0x0A> 0.1739501953125
E 1.0029296875
li 0.0295867919921875
▁L 0.0002875328063964844
illy 0.000701904296875
▁& 0.2037353515625
▁Co 0.0036067962646484375
' 1.5146484375
s 0.00024259090423583984
▁steady 7.1875
▁success 6.0
▁can 1.7294921875
▁be 0.0782470703125
▁attributed 0.09136962890625
▁to 0.0340576171875
▁a 2.724609375
▁range 2.408203125
▁of 0.00015032291412353516
▁factors 0.52490234375
, 0.400146484375
▁including 0.4736328125
▁its 1.724609375
▁strateg 3.93359375
ic 0.0184326171875
▁focus 1.6875
▁on 0.0164337158203125
▁innov 2.0625
ative 0.58740234375
▁medic 2.19921875
ines 0.3681640625
▁and 0.85400390625
▁strong 3.044921875
▁product 3.57421875
▁pipeline 1.5205078125
. 0.1148681640625
▁During 3.328125
▁the 0.070556640625
▁third 1.541015625
▁quarter 0.043914794921875
, 0.4013671875
▁the 0.41455078125
▁company 0.057220458984375
▁witness 3.4296875
ed 0.0004794597625732422
▁robust 1.7578125
▁sales 0.363525390625
▁of 0.453369140625
▁its 0.9677734375
▁block 3.396484375
b 0.000164031982421875
uster 0.009765625
▁dru 0.74072265625
gs 8.106231689453125e-06
, 0.50146484375
▁such 1.548828125
▁as 0.00013637542724609375
▁Tr 0.59912109375
ul 0.008087158203125
icity 0.007808685302734375
, 0.65625
▁T 2.373046875
alt 0.0010328292846679688
z 0.0023021697998046875
, 0.099853515625
▁and 0.353515625
▁J 2.103515625
ard 0.003520965576171875
iance 0.0014247894287109375
, 0.74365234375
▁all 2.814453125
▁of 0.1546630859375
▁which 0.0005698204040527344
▁contribute 4.43359375
▁significantly 0.55908203125
▁to 0.06427001953125
▁its 1.1171875
▁bottom 2.43359375
▁line 0.0477294921875
. 0.0116424560546875
▁The 2.078125
▁continued 4.453125
▁demand 1.5673828125
▁for 0.01238250732421875
▁these 0.11102294921875
▁medic 0.904296875
ations 0.7587890625
, 1.48828125
▁couple 1.94140625
d 1.728534698486328e-05
▁with 0.00014150142669677734
▁successful 5.515625
▁market 2.701171875
ing 0.0794677734375
▁strateg 1.533203125
ies 9.417533874511719e-06
▁and 2.212890625
▁en 4.84765625
hanced 0.00782012939453125
▁patient 2.353515625
▁access 0.395751953125
, 0.5771484375
▁is 2.63671875
▁anticip 3.171875
ated 9.381771087646484e-05
▁to 0.00043201446533203125
▁drive 0.865234375
▁substantial 4.54296875
▁re 1.421875
venue 0.00021696090698242188
▁growth 0.186767578125
. 1.50390625
<0x0A> 0.45361328125
Add 3.484375
itionally 0.00876617431640625
, 5.1975250244140625e-05
▁Eli 0.8662109375
▁L 0.0003941059112548828
illy 0.0005173683166503906
' 2.431640625
s 7.236003875732422e-05
▁recent 2.26171875
▁break 6.65625
through 0.0015850067138671875
▁in 1.0263671875
▁the 1.2568359375
▁development 0.984375
▁of 0.01050567626953125
▁COVID 1.904296875
- 0.0033206939697265625
1 0.0027179718017578125
9 0.00020515918731689453
▁treat 1.3037109375
ments 1.537799835205078e-05
▁has 1.138671875
▁further 1.3984375
▁bol 1.6103515625
ster 7.987022399902344e-06
ed 4.780292510986328e-05
▁its 0.5380859375
▁port 6.25390625
folio 0.0003197193145751953
. 1.099609375
▁The 0.463134765625
▁ph 4.7734375
arma 0.0011301040649414062
ce 0.15966796875
ut 0.0007190704345703125
ical 5.447864532470703e-05
▁company 2.1015625
' 0.8134765625
s 4.482269287109375e-05
▁mon 2.20703125
oc 0.0002155303955078125
l 6.16312026977539e-05
onal 1.3470649719238281e-05
▁ant 0.001819610595703125
ib 3.647804260253906e-05
ody 0.060211181640625
▁ther 0.97119140625
apy 0.20166015625
, 0.1636962890625
▁b 0.494873046875
am 0.00016438961029052734
lan 0.0008058547973632812
iv 0.0007848739624023438
im 0.00038504600524902344
ab 0.001331329345703125
, 0.048187255859375
▁received 3.001953125
▁Emer 2.0078125
gency 9.512901306152344e-05
▁Use 0.00539398193359375
▁Author 0.0014085769653320312
ization 0.00746917724609375
▁( 0.65869140625
E 0.0004239082336425781
U 0.0052337646484375
A 0.00017213821411132812
) 0.00766754150390625
▁from 0.09326171875
▁the 0.004058837890625
▁US 1.30859375
▁Food 0.0916748046875
▁and 0.033050537109375
▁D 0.0004773139953613281
rug 1.1920928955078125e-05
▁Administration 0.0013713836669921875
▁( 0.09686279296875
F 0.0016031265258789062
DA 1.6808509826660156e-05
). 2.66796875
▁This 0.70556640625
▁authorization 3.55859375
▁enables 2.587890625
▁Eli 2.013671875
▁L 0.0008187294006347656
illy 0.0006852149963378906
▁to 0.096435546875
▁supply 2.548828125
▁its 1.9033203125
▁potentially 5.62890625
▁life 0.390380859375
- 0.00022161006927490234
s 0.0016260147094726562
aving 5.447864532470703e-05
▁treatment 1.2861328125
▁to 0.16357421875
▁COVID 2.97265625
- 0.008453369140625
1 0.01242828369140625
9 6.747245788574219e-05
▁patients 0.0300445556640625
, 1.48828125
▁potentially 3.470703125
▁leading 2.78515625
▁to 0.0004475116729736328
▁substantial 3.58984375
▁sales 2.263671875
▁and 1.994140625
▁financial 4.9296875
▁g 0.333984375
ains 1.9073486328125e-06
. 0.266845703125
<0x0A> 0.097412109375
Con 2.787109375
c 0.0181732177734375
ern 9.059906005859375e-06
s 0.0174102783203125
▁Over 0.378662109375
▁Prof 0.1419677734375
it 0.00875091552734375
▁Marg 0.19482421875
ins 1.4901161193847656e-05
: 0.010589599609375
<0x0A> 0.0026702880859375
Wh 1.1611328125
ile 0.0003180503845214844
▁Eli 0.197509765625
▁L 0.0002770423889160156
illy 0.001617431640625
▁& 0.68798828125
▁Co 0.0013742446899414062
' 0.386474609375
s 0.00012695789337158203
▁rising 3.54296875
▁prof 0.2315673828125
its 9.775161743164062e-06
▁demonstrate 5.53515625
▁its 0.69580078125
▁strong 2.830078125
▁performance 1.625
, 0.6748046875
▁concerns 3.21875
▁persist 4.03125
▁over 0.51220703125
▁profit 3.72265625
▁marg 0.84814453125
ins 8.225440979003906e-06
. 0.2005615234375
▁The 1.8271484375
▁es 9.4375
cal 0.0001327991485595703
ating 0.16845703125
▁costs 0.87353515625
▁of 0.412109375
▁research 1.568359375
▁and 0.08258056640625
▁development 0.008209228515625
, 0.97705078125
▁couple 1.2705078125
d 5.0067901611328125e-06
▁with 6.556510925292969e-05
▁invest 6.421875
ments 0.1873779296875
▁in 0.05780029296875
▁expand 3.283203125
ing 0.00023412704467773438
▁its 0.90380859375
▁manufact 2.091796875
uring 5.793571472167969e-05
▁capabilities 1.119140625
, 0.19482421875
▁have 0.99365234375
▁s 4.92578125
que 0.018341064453125
ez 3.159046173095703e-05
ed 1.5020370483398438e-05
▁marg 2.083984375
ins 0.0001220703125
▁for 2.373046875
▁the 0.263671875
▁company 0.468505859375
. 0.05718994140625
▁Additionally 1.6142578125
, 3.075599670410156e-05
▁increased 2.751953125
▁competition 0.216552734375
▁within 3.32421875
▁the 0.055938720703125
▁ph 0.46142578125
arma 0.0005431175231933594
ce 0.01497650146484375
ut 6.80685043334961e-05
ical 8.463859558105469e-06
▁industry 0.1854248046875
, 1.6845703125
▁combined 3.333984375
▁with 5.5909156799316406e-05
▁the 1.904296875
▁imp 5.9921875
ending 0.1590576171875
▁exp 0.7958984375
iration 0.1202392578125
▁of 0.0077362060546875
▁pat 1.263671875
ents 0.056304931640625
▁for 0.62548828125
▁some 1.3916015625
▁of 0.270263671875
▁Eli 0.83740234375
▁L 0.0022182464599609375
illy 0.0024127960205078125
' 0.01236724853515625
s 5.173683166503906e-05
▁key 0.70751953125
▁dru 0.26220703125
gs 8.344650268554688e-07
, 0.01386260986328125
▁pos 3.064453125
es 0.00021195411682128906
▁potential 3.82421875
▁pr 6.82421875
icing 1.0132789611816406e-05
▁challeng 1.5126953125
es 7.152557373046875e-06
. 0.607421875
<0x0A> 0.317626953125
More 2.310546875
over 0.004123687744140625
, 3.504753112792969e-05
▁on 5.64453125
going 0.014892578125
▁discuss 4.91796875
ions 4.649162292480469e-06
▁on 3.384765625
▁drug 0.5419921875
▁pr 0.0887451171875
icing 3.9696693420410156e-05
▁re 2.7890625
forms 0.001308441162109375
▁within 4.0078125
▁the 0.03558349609375
▁US 0.12890625
▁health 1.1484375
care 0.01334381103515625
▁system 0.17919921875
▁could 1.576171875
▁significantly 3.28515625
▁impact 0.248291015625
▁the 2.765625
▁overall 6.91015625
▁profit 0.427978515625
ability 0.30712890625
▁of 0.0328369140625
▁ph 2.03125
arma 0.0005373954772949219
ce 0.0223541259765625
ut 2.384185791015625e-07
ical 2.7418136596679688e-06
▁companies 0.0537109375
▁like 2.056640625
▁Eli 0.0034770965576171875
▁L 0.0003490447998046875
illy 0.0005130767822265625
. 0.578125
▁Possible 8.6328125
▁changes 1.3916015625
▁to 0.6748046875
▁drug 1.8369140625
▁pr 0.315673828125
icing 4.9233436584472656e-05
▁policies 1.3876953125
▁and 2.544921875
▁increased 2.794921875
▁pressure 2.416015625
▁for 3.1640625
▁afford 2.3359375
able 0.1602783203125
▁access 3.3046875
▁to 0.11376953125
▁medic 0.2418212890625
ations 1.0517578125
▁could 0.3876953125
▁impact 3.20703125
▁the 1.05078125
▁company 0.255859375
' 0.006595611572265625
s 1.9788742065429688e-05
▁pr 3.16015625
icing 1.4185905456542969e-05
▁power 1.373046875
▁and 0.48828125
▁ex 8.0625
ert 0.0653076171875
▁down 0.65576171875
ward 0.00836944580078125
▁pressure 0.01375579833984375
▁on 0.0004563331604003906
▁marg 1.5361328125
ins 1.4662742614746094e-05
. 0.036102294921875
<0x0A> 0.09423828125
Out 3.455078125
look 0.004016876220703125
▁and 2.734375
▁Str 2.99609375
ateg 0.09954833984375
ies 0.210205078125
: 0.44091796875
<0x0A> 0.0034961700439453125
Des 0.54248046875
p 9.5367431640625e-07
ite 8.344650268554688e-07
▁the 0.9013671875
▁concerns 2.685546875
▁surrounding 0.66943359375
▁profit 0.63134765625
▁marg 0.06256103515625
ins 4.5180320739746094e-05
, 0.017333984375
▁Eli 0.2685546875
▁L 8.368492126464844e-05
illy 0.0001385211944580078
▁& 0.290771484375
▁Co 0.0009088516235351562
▁remains 0.78173828125
▁optim 0.85498046875
istic 5.793571472167969e-05
▁about 0.05230712890625
▁its 0.1392822265625
▁future 0.397705078125
▁growth 1.8349609375
▁prospect 0.302734375
s 7.963180541992188e-05
. 0.0245208740234375
▁The 0.1295166015625
▁ph 2.64453125
arma 0.0001125335693359375
ce 0.002288818359375
ut 1.5497207641601562e-06
ical 5.125999450683594e-06
▁manufact 8.1015625
urer 0.016326904296875
▁continues 2.701171875
▁to 0.006809234619140625
▁advance 5.95703125
▁its 0.1531982421875
▁robust 4.40234375
▁research 3.869140625
▁and 0.17724609375
▁development 0.0085906982421875
▁pipeline 0.381103515625
, 0.12335205078125
▁foc 2.37109375
using 0.0006375312805175781
▁on 0.022003173828125
▁innov 1.15625
ative 0.039398193359375
▁ther 1.4619140625
ap 0.0004119873046875
ies 4.887580871582031e-06
▁for 1.1552734375
▁various 1.9619140625
▁dise 0.84619140625
ases 1.704692840576172e-05
. 0.57763671875
▁Moreover 3.2265625
, 3.337860107421875e-05
▁the 0.3173828125
▁company 0.03985595703125
▁strateg 7.39453125
izes 2.23046875
▁to 0.30224609375
▁expand 1.4130859375
▁its 0.16796875
▁global 1.8125
▁presence 1.857421875
▁through 1.591796875
▁partners 1.71484375
hips 0.007171630859375
▁and 0.35009765625
▁ac 1.0966796875
quis 0.005817413330078125
itions 9.298324584960938e-06
, 0.53662109375
▁aim 1.4609375
ing 0.0263671875
▁to 0.0119171142578125
▁divers 2.765625
ify 0.00023567676544189453
▁its 0.0482177734375
▁re 0.611328125
venue 3.457069396972656e-05
▁streams 0.14794921875
▁and 0.272705078125
▁reduce 2.736328125
▁dependency 3.076171875
▁on 0.002925872802734375
▁individual 1.806640625
▁block 7.56640625
b 4.7087669372558594e-05
uster 0.0211944580078125
▁dru 0.06927490234375
gs 1.3113021850585938e-06
. 0.0072174072265625
<0x0A> 0.044097900390625
E 1.5732421875
li 0.029052734375
▁L 0.00022113323211669922
illy 0.0006785392761230469
▁& 0.65771484375
▁Co 0.0016269683837890625
▁is 1.91796875
▁also 1.517578125
▁eng 6.34765625
aging 0.0053558349609375
▁in 0.08349609375
▁on 5.0546875
going 0.0021991729736328125
▁efforts 1.642578125
▁to 0.0154571533203125
▁manage 4.94921875
▁costs 1.5537109375
▁effectively 2.974609375
▁and 1.048828125
▁optimize 2.3203125
▁its 0.5078125
▁manufact 1.375
uring 4.76837158203125e-06
▁processes 1.0498046875
. 0.49365234375
▁By 2.265625
▁en 4.26171875
han 0.005390167236328125
cing 0.0005002021789550781
▁oper 1.21875
ational 1.6450881958007812e-05
▁effic 0.8125
ien 0.00786590576171875
cies 8.702278137207031e-06
▁and 0.607421875
▁expl 4.81640625
oring 3.0159950256347656e-05
▁techn 5.671875
ological 0.044158935546875
▁adv 0.128662109375
anc 0.047515869140625
ements 8.58306884765625e-05
, 0.11663818359375
▁the 0.0406494140625
▁company 0.388916015625
▁a 0.7333984375
ims 1.1920928955078125e-06
▁to 0.0008611679077148438
▁counter 5.23046875
▁the 1.9638671875
▁challeng 1.4296875
es 0.0219268798828125
▁pos 1.0029296875
ed 0.0016336441040039062
▁by 0.01445770263671875
▁rising 1.5205078125
▁costs 0.7587890625
▁and 0.1397705078125
▁potential 4.55078125
▁pr 0.1639404296875
icing 1.3709068298339844e-05
▁press 0.578125
ures 1.5497207641601562e-06
. 0.068115234375
<0x0A> 0.22265625
Con 2.80078125
clusion 0.29931640625
: 0.05084228515625
<0x0A> 9.2109375
E 1.201171875
li 0.00948333740234375
▁L 8.726119995117188e-05
illy 0.0003147125244140625
▁& 0.03643798828125
▁Co 0.0013895034790039062
' 0.5224609375
s 0.000164031982421875
▁third 1.607421875
- 0.01971435546875
qu 0.00012123584747314453
arter 7.271766662597656e-06
▁ear 0.055267333984375
nings 0.0017919540405273438
▁are 0.51220703125
▁expected 1.029296875
▁to 0.0003249645233154297
▁show 2.689453125
case 0.44775390625
▁a 1.7119140625
▁strong 1.7978515625
▁up 7.5078125
ward 0.00962066650390625
▁traject 0.2073974609375
ory 7.3909759521484375e-06
▁in 3.54296875
▁prof 0.64453125
its 3.743171691894531e-05
, 0.478759765625
▁primarily 4.15625
▁fue 3.78515625
led 2.384185791015625e-07
▁by 8.857250213623047e-05
▁robust 0.283447265625
▁sales 0.09454345703125
▁of 0.0255584716796875
▁their 5.8046875
▁block 1.5849609375
b 3.790855407714844e-05
uster 0.0011720657348632812
▁dru 0.052520751953125
gs 2.384185791015625e-07
▁and 1.01171875
▁break 2.44921875
through 0.0006556510925292969
s 1.3671875
▁in 0.004611968994140625
▁COVID 0.7890625
- 0.0011472702026367188
1 0.0013284683227539062
9 0.00024259090423583984
▁treat 0.2366943359375
ments 1.1920928955078125e-05
. 0.0034732818603515625
▁However 0.8671875
, 8.463859558105469e-05
▁concerns 0.67333984375
▁l 3.849609375
inger 0.0030384063720703125
▁over 0.1097412109375
▁their 4.8515625
▁profit 0.2286376953125
▁marg 0.135009765625
ins 3.826618194580078e-05
, 0.2431640625
▁stem 3.404296875
ming 0.00048422813415527344
▁from 0.005268096923828125
▁rising 1.041015625
▁costs 0.4453125
▁of 1.7958984375
▁research 0.1358642578125
▁and 0.016387939453125
▁development 0.00466156005859375
, 0.1947021484375
▁potential 4.37890625
▁pr 0.13525390625
icing 1.6808509826660156e-05
▁press 0.457275390625
ures 3.933906555175781e-06
, 0.097900390625
▁and 0.007015228271484375
▁drug 3.748046875
▁pr 0.033050537109375
icing 7.271766662597656e-06
▁re 0.123046875
forms 0.0001285076141357422
. 0.363037109375
▁The 2.6171875
▁company 0.49365234375
' 2.08984375
s 4.1365623474121094e-05
▁future 3.6796875
▁success 2.666015625
▁h 1.384765625
ing 8.189678192138672e-05
es 0.0001093149185180664
▁on 0.04229736328125
▁its 0.54931640625
▁ability 0.340576171875
▁to 9.322166442871094e-05
▁effectively 1.599609375
▁manage 0.1995849609375
▁these 0.67919921875
▁challeng 0.2020263671875
es 0.00012028217315673828
, 1.681640625
▁while 0.412109375
▁continu 1.2529296875
ing 0.019927978515625
▁to 0.0298309326171875
▁innov 1.623046875
ate 0.0002760887145996094
▁and 0.0443115234375
▁expand 0.5146484375
▁its 0.1546630859375
▁product 1.859375
▁port 0.2059326171875
folio 0.0002498626708984375
. 0.10400390625
